🔗 Permalink

Inventor profile of:

Paul A. Marks

City:

Washington, Connecticut

Country:

United States

Published Applications:

Last publication date:

2017-03-09

Top Assignees for applications by Paul A. Marks

The entities that hold a legal rights for patent applications filed by inventor Marks Paul A.:

Sloan-Kettering Institute for Cancer Research 13 New York, NY United States
The Trustees of Columbia University in the City of New York 7 New York, NY United States
Sloan-Kettering Institute for Cancer Research 1 New York ny, NY United States

Recent patent applications by Marks Paul A.

Paul A. Marks from Washington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-03-09

US20170066712A1

Chemistry; metallurgy

NOVEL MOLECULES THAT SELECTIVELY INHIBIT HISTONE DEACETYLASE 6 RELATIVE TO HISTONE DEACETYLASE

#2 | 2014-09-25

US20140288119A1

Chemistry; metallurgy

Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1

#3 | 2014-01-30

US20140031368A1

Chemistry; metallurgy

SELECTIVE HDAC INHIBITORS

#4 | 2012-10-25

US20120270818A1

Human necessities

HDAC 6 inhibitor-based methods for treating cancer

#5 | 2011-05-26

US20110124731A1

Human necessities

Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors

#6 | 2010-10-28

US20100273732A1

Human necessities

COMBINATION METHODS OF TREATING CANCER

#7 | 2009-02-26

US20090054720A1

Human necessities

Use of histone deacetylase inhibitors in combination with radiation for the treatment of cancer

#8 | 2008-09-11

US20080221308A1

Chemistry; metallurgy

Antibodies that selectively bind HDAC9

#9 | 2007-08-16

US20070190022A1

Human necessities

Combination methods of treating cancer

#10 | 2007-07-05

US20070155785A1

Chemistry; metallurgy

Hydroxamic acid compounds and methods of use thereof

#11 | 2007-05-03

US20070100559A1

Chemistry; metallurgy

Crystal structure of a deacetylase and inhibitors thereof

#12 | 2007-04-19

US20070087427A1

Chemistry; metallurgy

Crystal structure of a deacetylase and inhibitors thereof

#13 | 2007-04-03

US10817688

Hydroxamic acid compounds and methods of use thereof

#14 | 2007-01-11

US20070010669A1

Chemistry; metallurgy

Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#15 | 2007-01-11

US20070010536A1

Chemistry; metallurgy

Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#16 | 2006-10-26

US20060241129A1

Chemistry; metallurgy

Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#17 | 2006-10-24

US10281875

Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#18 | 2006-10-17

US10095109

Crystal structure of a deacetylase and inhibitors thereof

#19 | 2006-06-20

US10173539

HDAC9 polypeptides and polynucleotides and uses thereof

#20 | 2006-04-13

US20060079551A1

Human necessities

Treatment of cancer of the brain using histone deacetylase inhibitors

#21 | 2006-02-09

US20060030019A1

Chemistry; metallurgy

HDAC9 polypeptides and polynucleotides and uses thereof

#22 | 2006-01-12

US20060009527A1

Human necessities

Method of treating TRX mediated diseases

#23 | 2006-01-12

US20060009526A1

Human necessities

Method of treating TRX mediated diseases

#24 | 2005-12-29

US20050288227A1

Chemistry; metallurgy

Use of thioredoxin measurements for diagnostics and treatments

InventorID:

632641 ⎘